Get the Stockscreener App
9.85
5.01%
0.47
After Hours:
9.98
0.13
+1.32%
Corvus Pharmaceuticals Inc Stock (CRVS) Forecast
The Corvus Pharmaceuticals Inc (CRVS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $8.7061, representing a -11.61% decrease from the current price of $9.85. The highest analyst price target is $9.7507, and the lowest is $7.6614.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRVS Price Target
Average 7.7536
(-21.28% Downside)
Is Corvus Pharmaceuticals Inc (CRVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.99 | Neutral |
| STOCH(9,6) | 16.32 | Buy |
| STOCHRSI(14) | 59.07 | Neutral |
| MACD(12,26) | -0.9384 | Sell |
| ADX(14) | 31.45 | Sell |
| William %R | -80.06 | Buy |
| CCI(14) | -52.98 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.20
Sell
|
10.23
Sell
|
| MA20 |
11.12
Sell
|
10.97
Sell
|
| MA50 |
12.91
Sell
|
12.23
Sell
|
| MA100 |
13.12
Sell
|
12.92
Sell
|
| MA200 |
14.27
Sell
|
12.23
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CRVS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CRVS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.99 indicates that CRVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.32 indicates that CRVS is oversold. This indicates that CRVS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 59.07 indicates that CRVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.45 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -52.98 indicates that CRVS is still oversold but not to an extreme extent.
Long-term CRVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Corvus Pharmaceuticals Inc financial reports and earnings history, Corvus Pharmaceuticals Inc (CRVS) stock could reach $11.51 by 2030, $21.53 by 2040 and $26.33 by 2050. See the projected annual prices until 2050 of the Corvus Pharmaceuticals Inc stock below:
- Corvus Pharmaceuticals Inc (CRVS) is expected to reach an average price of $14.59 in 2035, with a high prediction of $14.93 and a low estimate of $14.13. This indicates an $48.13% rise from the last recorded price of $9.85.
- Corvus Pharmaceuticals Inc (CRVS) stock is projected to chart a bullish course in 2040, with an average price target of $19.75, representing an $100.53% surge from its current level. The forecast ranges from a conservative $19.40 to a sky-high $21.53.
- Our analysts predict Corvus Pharmaceuticals Inc (CRVS) to jump 126.17% by 2045, soaring from $22.01 to an average price of $22.28, potentially reaching $22.34. While $22.01 is the low estimate, the potential upside is significant.
- Corvus Pharmaceuticals Inc (CRVS) stock is expected to climb by 2050, reaching an average of $25.74, a $161.35% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.33 and $25.64, respectively, highlighting the market's uncertainty.
Corvus Pharmaceuticals Inc Stock (CRVS) Year by Year Forecast
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2026
The predicted value for Corvus Pharmaceuticals Inc (CRVS) in 2026 is set at an average of $16.67. Estimates vary from a peak of $26.95 to a trough of $6.39, indicating an +69.24% surge from the present price of $9.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $7.9414 | $7.6614 | $9.7507 | -19.38% |
| December, 2026 | $7.3157 | $7.1557 | $8.1986 | -25.73% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Corvus Pharmaceuticals Inc (CRVS) is $6.5779, with a high forecast of $7.3993 and a low forecast of $5.7565. This indicates an -33.22% decrease from the last price of $9.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.89 | $6.69 | $7.3993 | -30.05% |
| February, 2027 | $6.5243 | $6.2271 | $6.9036 | -33.76% |
| March, 2027 | $6.2921 | $6.2921 | $6.8778 | -36.12% |
| April, 2027 | $6.4564 | $6.1393 | $6.6418 | -34.45% |
| May, 2027 | $6.1942 | $6.1607 | $6.9535 | -37.11% |
| June, 2027 | $6.0185 | $5.8785 | $6.2878 | -38.90% |
| July, 2027 | $6.0428 | $5.9138 | $6.2292 | -38.65% |
| August, 2027 | $6.0517 | $5.7565 | $6.2871 | -38.56% |
| September, 2027 | $6.1449 | $5.934 | $6.1749 | -37.61% |
| October, 2027 | $6.0772 | $6.0692 | $6.3336 | -38.30% |
| November, 2027 | $6.1767 | $5.9185 | $6.2511 | -37.29% |
| December, 2027 | $6.1583 | $6.1017 | $6.254 | -37.48% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2028
In 2028, Corvus Pharmaceuticals Inc (CRVS) is projected to reach an average price of $8.0125, with a high projection of $9.9699 and a low estimate of $6.0551. This indicates an -18.66% fall from the last price of $9.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.2914 | $6.0551 | $6.3005 | -36.13% |
| February, 2028 | $6.2477 | $6.0999 | $6.5563 | -36.57% |
| March, 2028 | $6.3416 | $6.187 | $6.4043 | -35.62% |
| April, 2028 | $6.3221 | $6.2614 | $6.392 | -35.82% |
| May, 2028 | $6.2399 | $6.1999 | $6.3942 | -36.65% |
| June, 2028 | $6.7242 | $6.2376 | $6.9142 | -31.73% |
| July, 2028 | $7.762 | $6.6351 | $8.052 | -21.20% |
| August, 2028 | $8.9663 | $7.8406 | $9.4256 | -8.97% |
| September, 2028 | $8.1106 | $7.7706 | $9.9699 | -17.66% |
| October, 2028 | $8.1384 | $8.0049 | $9.0077 | -17.38% |
| November, 2028 | $8.0127 | $7.9191 | $8.3727 | -18.65% |
| December, 2028 | $7.577 | $7.5034 | $8.3863 | -23.08% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2029
The 2029 price forecast for Corvus Pharmaceuticals Inc Stock (CRVS) is $8.9423 on average, with a high prediction of $10.76 and a low estimate of $7.1284. This represents an -9.22% decrease from the previous price of $9.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.2998 | $7.2548 | $7.6206 | -25.89% |
| February, 2029 | $7.5091 | $7.1284 | $7.8991 | -23.77% |
| March, 2029 | $7.7834 | $7.3627 | $7.8034 | -20.98% |
| April, 2029 | $8.3012 | $7.6205 | $8.5112 | -15.72% |
| May, 2029 | $8.2955 | $8.152 | $8.6748 | -15.78% |
| June, 2029 | $8.6998 | $8.2627 | $8.9027 | -11.68% |
| July, 2029 | $8.2077 | $8.1277 | $8.8136 | -16.67% |
| August, 2029 | $7.8719 | $7.7719 | $8.3826 | -20.08% |
| September, 2029 | $8.6062 | $7.8755 | $8.7162 | -12.63% |
| October, 2029 | $8.6341 | $8.4969 | $8.9034 | -12.34% |
| November, 2029 | $8.6983 | $8.3848 | $8.7133 | -11.69% |
| December, 2029 | $10.69 | $8.6219 | $10.76 | +8.49% |
Corvus Pharmaceuticals Inc Stock (CRVS) Price Forecast for 2030
Corvus Pharmaceuticals Inc Stock (CRVS) is expected to reach an average price of $13.36 in 2030, with a high forecast of $16.93 and a low forecast of $9.7854. This signifies an +35.63% surge from the last price of $9.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.80 | $10.19 | $11.51 | +9.65% |
| February, 2030 | $12.10 | $10.78 | $12.95 | +22.89% |
| March, 2030 | $15.19 | $11.64 | $15.57 | +54.20% |
| April, 2030 | $15.90 | $14.71 | $16.93 | +61.39% |
| May, 2030 | $11.99 | $10.77 | $16.51 | +21.74% |
| June, 2030 | $12.39 | $11.53 | $13.53 | +25.74% |
| July, 2030 | $12.00 | $11.67 | $12.76 | +21.86% |
| August, 2030 | $11.70 | $11.00 | $12.12 | +18.76% |
| September, 2030 | $10.23 | $9.7854 | $11.96 | +3.81% |
| October, 2030 | $10.92 | $10.23 | $11.05 | +10.86% |
| November, 2030 | $11.13 | $10.48 | $11.86 | +13.04% |
| December, 2030 | $11.42 | $10.96 | $12.00 | +15.96% |
4.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):